Physiology-guided cardioneuroablation for vagally mediated syncope and functional bradyarrhythmias
Authors:
- Gurukripa N. KowlgiGKGurukripa N. Kowlgi
- J. C. Pachón-MJPJ. C. Pachón-M
- Narut PrasitlumkumNPNarut Prasitlumkum
- Nicholas Y. TanNicholas Y. Tan
- Alan M. SugrueASAlan M. Sugrue
- Ammar M. KilluAKAmmar M. Killu
- Abhishek J. DeshmukhADAbhishek J. Deshmukh
- Suraj KapaSKSuraj Kapa
- Christopher V. DeSimoneChristopher V. DeSimone
Preprint
Abstract
Background: Vagally mediated syncope and functional bradyarrhythmias can cause recurrent symptoms, injury and a need for permanent pacing, yet standard therapies do not address the underlying autonomic reflex. Cardioneuroablation (CNA) targets this mechanism, but adoption has been limited by uncertainty about patient selection, procedural endpoints and durable outcomes. Methods: We studied 95 consecutive patients with vagally mediated syncope (n=78) or functional bradyarrhythmia (n=17) who underwent CNA at a single center by a single lead operator under a uniform, prospectively maintained protocol. Extracardiac vagal stimulation (ECVS) was performed before and after ablation to confirm vagally mediated sinus or atrioventricular (AV) nodal responses and to verify their attenuation. Outcomes through 1 year included clinical recurrence, quality of life, pacing burden and pacemaker extraction. Results: Before ablation, ECVS provoked sinus pauses in 95.8% of patients and AV block in 91.6%; after ablation, sinus pauses were abolished in every patient and residual AV block was present in 4.2%. One-year freedom from recurrent syncope and from bradyarrhythmia-related events was 93.8% and 94.1%. Syncope burden fell from a median of 2.7 episodes per year to none, and disease-specific quality of life improved substantially (P<0.001). Among patients with pre-existing devices, atrial pacing burden fell from a median of 22% to 0%. There were no strokes, deaths or myocardial infarctions. Conclusions: In this single-center cohort, physiology-guided CNA was associated with durable symptom control, improved quality of life and reduced pacing across vagally mediated bradyarrhythmia syndromes. Multicenter controlled studies are needed to confirm these findings.Keywords
This publication has 13 references indexed in Scilit:
- Physiological Markers of Effective Autonomic Denervation Are Associated With Outcomes After Cardioneuroablation for Vasovagal SyncopeJACC: Clinical Electrophysiology, 2026
- Successful cardioneural ablation for deglutition syncopeHeart & Lung, 2026
- Cardioneural Ablation for Functional Bradycardia and Vasovagal SyncopeJACC: Clinical Electrophysiology, 2025
- The Efficacy of Left Atrial vs Biatrial Cardioneuroablation in Patients With Vasovagal SyncopeJACC: Clinical Electrophysiology, 2025
- Cardioneuroablation for the treatment of reflex syncope and functional bradyarrhythmias: A Scientific Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS) and the Latin American Heart Rhythm Society (LAHRS)EP Europace, 2024
- Procedural and Intermediate-term Results of the Electroanatomical-guided Cardioneuroablation for the Treatment of Supra-Hisian Second- or Advanced-degree Atrioventricular Block: the PIRECNA multicentre registryEP Europace, 2024
- Cardioneuroablation for vasovagal syncope. Results from an EHRA SurveyEP Europace, 2024
- Cardioneuroablation for vasovagal syncope: A systematic review and meta-analysisHeart Rhythm, 2022
- Simplified Method for Vagal Effect Evaluation in Cardiac Ablation and Electrophysiological ProceduresJACC: Clinical Electrophysiology, 2015
- “Cardioneuroablation” – new treatment for neurocardiogenic syncope, functional AV block and sinus dysfunction using catheter RF-ablationEP Europace, 2005